| Combination therapy for the treatment of pulmonary arterial hypertension. | |
| | |
MedLine Citation:
|
PMID: 21849335 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Multiple medical therapies have been developed for the treatment of pulmonary arterial hypertension (PAH) over the last decade and a half. Unfortunately, none of these medications is curative and the majority of patients develop disease progression despite treatment. Presently available medications target one of three known pathways that have been implicated in disease pathogenesis. The multiplicity of pulmonary vascular abnormalities identified in PAH provides the rationale for a therapeutic strategy that targets more than one mechanism at a time. Although a handful of studies have demonstrated clinical improvement in PAH patients who have a second medication added to stable background therapy in a randomized, placebo-controlled fashion, it is unclear whether the derived benefit is due to the combination of two therapies or merely the response to the new agent. This review discusses the rationale for combination therapy, critically reviews the findings of presently completed combination studies and outlines the need for new studies that are better designed to determine whether combination therapy is more efficacious than single agent therapies for the treatment of PAH. |
| | |
Authors:
|
Andrew T Levinson; James R Klinger |
Related Documents
:
|
8703095 - Molecular evidence for acanthocephala as a subtaxon of rotifera. 21335815 - Development of a customizable software application for medical imaging analysis and vis... 14635825 - Extemporaneous compounding of pain and symptom control medications. 11817855 - La partera profesional: articulating identity and cultural space for a new kind of midw... 3968945 - Medical and legal management of adult acute epiglottitis. 6859055 - Numbers are better than words. verbal specifications of frequency have no place in medi... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-8-17 |
Journal Detail:
|
Title: Therapeutic advances in respiratory disease Volume: - ISSN: 1753-4666 ISO Abbreviation: - Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-8-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101316317 Medline TA: Ther Adv Respir Dis Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Division of Pulmonary, Sleep and Critical Care Medicine, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A framework for evaluating the appropriateness of clinical decision support alerts and responses.
Next Document: The ability of a behaviour-specific patient questionnaire to identify poorly performing doctors.